Symbol="QLGN"
AssetType="Common Stock"
Name="Qualigen Therapeutics Inc"
Description="Qualigen, Inc., a biotechnology company, develops new therapeutic products for the treatment of cancer and infectious diseases. The company is headquartered in Carlsbad, California."
CIK="1460702"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1880 CENTURY PARK EAST, SUITE 1000, LOS ANGELES, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="5911900"
EBITDA="-16445027"
PERatio="None"
PEGRatio="None"
BookValue="0.964"
DividendPerShare="0"
DividendYield="0"
EPS="-4.17"
RevenuePerShareTTM="1.398"
ProfitMargin="0"
OperatingMarginTTM="-2.833"
ReturnOnAssetsTTM="-0.6"
ReturnOnEquityTTM="-2.112"
RevenueTTM="5868700"
GrossProfitTTM="680800"
DilutedEPSTTM="-4.17"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.226"
AnalystTargetPrice="22.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1.178"
PriceToBookRatio="0.492"
EVToRevenue="0.368"
EVToEBITDA="-0.105"
Beta="0.0588"
num_52WeekHigh="4.715"
num_52WeekLow="0.83"
num_50DayMovingAverage="0.988"
num_200DayMovingAverage="1.316"
SharesOutstanding="5052500"
DividendDate="2020-05-26"
ExDividendDate="None"
symbol="QLGN"
open="1.18"
high="1.20"
low="1.13"
price="1.13"
volume="15898.00"
latest_trading_day="2023-07-31"
previous_close="1.17"
change="-0.04"
change_percent="-3.4271%"
aroon_positive_momentum_days="30"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="30"
Volume_recent_avg="118125"
Change_recent_avg="-0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.73"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_30"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="30"
Aroon_momentum_negative="70"
image_negative_thumbnail_id_1="1160"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0194.jpeg"
image_negative_thumbnail_id_2="97"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0079.jpeg"
image_neutral_thumbnail_id_1="562"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_neutral_thumbnail_id_2="529"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_positive_thumbnail_id_1="669"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0039.jpeg"
image_positive_thumbnail_id_2="706"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0002.jpeg"
image_professor_thumbnail_id_1="1192"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
